|
|
42, rue du Docteur Blanche
Paris, 75016 France
phone:+33 (0) 1 44 30 43 31
fax:+33 (0) 1 44 30 43 21
|
|
| Symbol |
IPN |
| Exchange |
EPA |
| Founded |
0 |
| Employees |
|
|
|
| www.ipsen.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Pharmaceuticals for oncology, endocrinology, and neuromuscular disorders. |
|
| Management |
| Jean-Luc Belingard, Chairman and Chief Executive Officer; Frederic Babin; Vice-President, Human Resources; Claude Bertrand, Vice-President Chief Scientific Officer; Eric Drape, Vice-President Manufacturing and Supply Organisation; Claire Giraut, Vice-President Chief Financial Officer |
| |
|
|
|
|
|
|
|
| Keywords |
| oncology, endocrinology, neurology and hematology, protein |
|
|
|
| Description |
|
Ipsen is the fifth largest French pharmaceutical company with over 20 marketed pharmaceutical and biotechnology products, primarily in endocrinology, oncology, neurology and haematology. |
|
| Products / Services |
ONCOLOGY: Décapeptyl, Somatuline
ENDOCRINOLOGY: Somatuline, Somatuline - Autogel, NutropinAq, Increlex
NEUROLOGY: Dysport, Apokyn
PRIMARY CARE: Nisis - Nisisco, Forlax - Fortrans, Tanakan, Smecta
|
|
| Technology / Differentiation |
| The Group's product portfolio includes medicinal products marketed to specialists working in its targeted disease areas (oncology, endocrinology and neuromuscular disorders) which represent its priority lines of development together with products marketed in other therapeutic areas related to the Group's historical expertise (gastroenterology, cardiovascular and cognitive disorders), for the most part prescribed in primary care in France. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
